The technology is said to be twice as accurate at predicting five-year cancer risk compared to current risk assessment methods.

Experts are hopeful their device can address some of the shortcomings of currently used shielding methods. 

The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Considering the often-aggressive nature of interval breast cancer, the findings could represent a significant step toward improving patient outcomes, authors of a new research paper suggest.

The American College of Radiology requested the update in June, with the changes now taking effect this month. 

Variable technologist training and skill levels, inconsistent onboarding and training, “constant” turnover, and a high number of unfilled positions all have contributed. 

New global survey data suggest organizations have not let the lack of reimbursement affect their decision to implement CEM. 

Among 1,600 U.S. adults surveyed, about 49% said they know that age 40 is when women at average risk should begin screening. 

The photoacoustic CT, or PACT, imaging technique is said to perform comparably to mammography for cancer detection, but without the discomfort of standard mammograms. 

The agent “exhibits powerful tumor delineation” in challenging cases of determining cancer subtypes, and could potentially lead to more personalized, effective treatment strategies.